CANADIAN ILLICIT OPIATE USERS’ VIEWS ON METHADONE AND OTHER OPIATE PRESCRIPTION TREATMENT: AN EXPLORATORY QUALITATIVE STUDY

REFERENCES

• Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J., Medved W., Blake J. The Social Cost of Un-treated Opiate Use. J. Urban Health 2001; 77: 688–722
   Google Scholar
• Fischer B., Medved W., Gliksman L., Rehm J. Illicit Opiates in Toronto: A Profile of Current Users. Addiction Res. 1999; 7(5)377–415
   Google Scholar
• Deschenes E., Anglin D., Speckart G. Narcotics Addiction: Related Criminal Careers Social and Economic Costs. J. Drug Issues 1991; 21: 383–411
   Web of Science ®Google Scholar
• National Institute of Health/National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective Medical Treatment of Opiate Addiction. J. Am. Med. Assoc. 1998; 280: 1936–1943
   Google Scholar
• NIDA. Methadone Maintenance Treatment Translating Research into Policy. National Institute on Drug Abuse, Bethesda 1995
   Google Scholar
• Ralston G., Wilson P. Methadone Programs—The Costs and Benefits to Society. Pharmacoeconomics 1996; 10(4)321–326
   PubMedGoogle Scholar
• Federal Regulation of Methadone Treatment, R.A. Rettig, A. Yarmolinsky. National Academy Press, Washington, DC 1995
   Google Scholar
• Bertschy G. Methadone Maintenance Treatment: An Update. Gen.Arch. Psychiatry Clin. Neurosci. 1995; 245: 114–124
   PubMed Web of Science ®Google Scholar
• Sells S., Demaree R., Hornick C. Comparative Effectiveness of Drug Abuse Treatment Modalities. NIDA Service Research Administrative Report. NIDA, Washington, DC 1979
   Google Scholar
• Hubbard R., Marsden M. Relapse to Use of Heroin, Cocaine and Other Drugs in the First Year After Treatment. Relapse and Recovery in Drug Abuse. NIDA Research Monograph 72, USGPO, Rockville 1986
   Google Scholar
• Kuo I., Fischer B., Vlahov D. Consideration of a North American Heroin-Assisted Trial for the Treatment of Opiate-Dependent Individuals. Int. J. Drug Policy 2000; 11: 357–370
   PubMedGoogle Scholar
• Flaherty E., Olsen K., Bencivengo M. Predicting Changes in Drug Use and Treatment Entry for Local Programs: A Case Study. Am. J. Drug Alcohol Abuse 1980; 7: 31–48
   PubMed Web of Science ®Google Scholar
• Beschner G.M., Walters J.M. Just Another Habit? The Heroin Users’ Perspective. Life with Heroin: Voices from the Inner City, B. Hanson, G. Beschner, J. Walters, E. Bovelle. D.C. Heath and Company, Lexington, MA 1985
   Google Scholar
• Hunt D.E., Lipton D.S., Goldsmith D.S., Strug D.L., Spunt B. It Takes Your Heart: The Image of Methadone Maintenance in the Addict World and Its Effect on Recruitment into Treatment. Int. J. Addictions 1986; 20: 1751–1771
   Google Scholar
• Koester S., Anderson K., Hoffer L. Active Heroin Injectors’ Perceptions and Use of Methadone Maintenance Treatment: Cynical Performance or Self-Prescribed Risk Reduction?. Substance Use Misuse 1999; 34(14)2135–2153
   PubMed Web of Science ®Google Scholar
• Bammer G., Dobler-Mikola A., Fleming P., Strang J., Uchtenhagen U. Prescribing Heroin to Dependent Users—Integrating Science and Politics. Science 1999; 284(5418)1277–1278
   PubMed Web of Science ®Google Scholar
• Fischer B., Rehm J. The Case for a Heroin Substitution Treatment Trial in Canada. Can. J. Pub. Health 1997; 88(6)367–370
   PubMedGoogle Scholar
• Kemmesies U. Offene Drogenszene und Druckräume. Wiener Zeitschrift für Suchtforschung 1996; 19(3/4)17–32
   Google Scholar
• Buning E. Demethadonverstrekking in Ciifers. Municipal Health Services, Amsterdam 1986
   Google Scholar
• Hser Y., Anglin M., Powers K. A 24-Year Follow-Up of California Narcotics Addicts. Arch. Gen. Psychiatry 1993; 50: 577–584
   PubMed Web of Science ®Google Scholar
• Strathdee S., Patrick D., Currie S., Cornelisse P., Rekart M., Montaner J., Schechter M., O’Shaughnessy M. Needle Exchange is Not Enough: Lessons from the Vancouver Injection Drug Use Study. AIDS 1997; 11: F59–F64
   PubMed Web of Science ®Google Scholar
• Bruneau J., Lamothe F., Franco E., Lachance N., Désy M., Soto J., Vincelette J. High rates of HIV Infections Among Injection Drug Users Participating in Needle Exchange Programs in Montreal: Results of a Cohort Study. Am. J. Epidem. 1997; 146(12)992–1002
   Google Scholar
• Hankins C., Barlow K., Black S., Cartledge V., Dineen C., Elliott D., Higgins K., Kearns B., Kendall P., Matsuko P., O’Shaughnessy M. HIV, AIDS and Injection Drug Use a National Action Plan. Health Canada, Ottawa 1997
   Google Scholar
• Millar J.S. HIV, Hepatitis,and Injection Drug Use in British Columbia:Pay Now or Pay Later?. Ministry of Health and Ministry Responsible for Seniors, , British Columbia 1998
   Google Scholar
• Fischer B., Rehm J., Blitz-Miller T. Injection Drug Use and Preventive Measures: A Comparison of Canadian and Western European Jurisdictions Over Time. Can. Med. Assoc. J. 2000; 162(12)1709–1713
   Web of Science ®Google Scholar
• Nurco D.N., Ball J.C., Shaffer J.W., Hanlon T.E. The Criminality of Narcotic Addicts. J. Nerv. Ment. Disorders 1985; 173: 94–102
   PubMed Web of Science ®Google Scholar
• Rosenbaum M., Murphy S. Women and Addiction: Process, Treatment, and Outcome. NIDA Res. Monogr. 1990; 98: 120–127
   PubMedGoogle Scholar
• Wenger L.D., Rosenbaum M. Drug Treatment on Demand—Not. J. Psychoactive Drugs 1994; 26(1)1–11
   PubMed Web of Science ®Google Scholar
• Gold M.L., Sorensen J.L., McCanlies N., Trier M., Dlugosch G. Tapering from Methadone Maintenance: Attitudes of Clients and Staff. J. Substance Abuse Treat. 1988; 5(1)37–44
   PubMed Web of Science ®Google Scholar
• Caplehorn J., Batey R. Methadone Maintenance in Australia. J. Drug Issues 1992; 22: 661–678
   Web of Science ®Google Scholar
• Caplehorn J., Bell J. Methadone Dosage and Retention of Patients in Methadone Maintenance. Med. J. Australia 1991; 154: 195–199
   PubMed Web of Science ®Google Scholar
• Bell J., Ward J., Mattick R., Hay A., Chan J., Hall W. An Evaluation of Private Methadone Clinics. National Drug Strategy Research Report No. 4. Australian Government Publishing Service: Canberra, 1995
   Google Scholar
• Hunt D.E., Lipton D.S., Goldsmith D.S., Strug D.L. Problems in Methadone Treatment: The Influence of Reference Groups. NIDA Res. Monogr. 1984; 46: 8–21
   PubMedGoogle Scholar
• Rosenbaum M., Murphy S. Getting the Treatment: Recycling Women Addicts. J. Psychoact. Drugs 1981; 13(1)1–13
   PubMed Web of Science ®Google Scholar
• Brown B., Benn G., Jansen D.R. Methadone Maintenance: Some Client Opinions. Am. J. Psychiatry 1975; 132(6)623–626
   PubMed Web of Science ®Google Scholar
• Van Manen M. Researching Lived Experience: Human Science for an Action Sensitive Pedagogy. Althouse Press, London, ON 1990
   Google Scholar
• Coffey A., Atkinson P. Making Sense of Qualitative Data. Sage, Thousand Oaks 1996
   Google Scholar
• Fischer B. Prescriptions, Power and Politics: The Turbulent History of Methadone Maintenance in Canada. J. Pub. Health Policy 2000; 21: 187–210
   PubMed Web of Science ®Google Scholar
• Cain V. Report of the Task Force Into Illicit Narcotic Overdose Deaths in British Columbia. Office of the Chief Coroner, Burnaby 1994
   Google Scholar
• Zule W.A., Desmond D.P. Attitudes Toward Methadone Maintenance: Implications for HIV Prevention. J. Psychoactive Drugs 1998; 30(1)89–97
   PubMed Web of Science ®Google Scholar
• Le Dain Commission. Commission of Inquiry into the Non-Medical Use of Drugs—Treatment Report. Information Canada, Ottawa 1972
   Google Scholar
• Hughes R. It's Like Having Half a Sugar When You Were Used to Three”—Drug Injectors’ Views and Experiences of Substitute Drug Prescribing Inside English Prisons. Int. J. Drug Policy 2000; 10: 455–466
   Google Scholar
• Canadian HIV/AIDS Legal Network. Injection Drug Use and HIV: Legal and Ethical Issues. Canadian HIV/AIDS Network, Montreal 1999
   Google Scholar
• Bammer G., Weekes S. Becoming an Ex-User: Would the Controlled Availability of Heroin Make a Difference?; Feasibility Research into the Controlled Availability of Opioids, Stage 2 Working Paper 4. National Centre for Epidemiology and Population Health, Australian National University, Canberra 1993
   Google Scholar
• Bammer G. Report and Recommendations: Feasibility Research into the Controlled Availability of Opioids. National Centre for Epidemiology and Population Health and the Australian Institute of Criminology, Canberra 1995
   Google Scholar
• Krausz M., Uchtenhagen A., van den Brink W. Medically Indicated Heroin Prescription in the Treatment of Drug Addicts: Clinical Trials and Developments in Research in Europe. Sucht 1999; 45(3)171–186
   Google Scholar
• Expanding Treatment Options for Heroin Dependence in Victoria: Buprenorphine, LAAM, Naltrexone and Slow-Release Oral Morphine.New Pharmacotherapies Project—Feasibility Phase, A. Ritter, J. Kutin, N. Lintzeris, G. Bammer. Turning Point Alcohol and Drug Centre Inc., Fitzroy, Victoria 1997
   Google Scholar